Page last updated: 2024-11-01

nimodipine and Hemolysis

nimodipine has been researched along with Hemolysis in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, H1
Katada, K1
Orita, M1
Nishikibe, M1
Fleckenstein-GrĂ¼n, G1
Fleckenstein, A1

Other Studies

2 other studies available for nimodipine and Hemolysis

ArticleYear
Effects of calcium antagonists on the erythrocyte membrane.
    The Journal of pharmacy and pharmacology, 1991, Volume: 43, Issue:1

    Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Erythrocyte Membrane; Hemolysis; Male; Microsco

1991
Prevention of cerebrovascular spasms with nimodipine.
    Stroke, 1990, Volume: 21, Issue:12 Suppl

    Topics: Animals; Basilar Artery; Brain; Calcium; Coronary Vessels; Guinea Pigs; Hemolysis; Ischemic Attack,

1990